Recommendations Developed for Addressing Child Trafficking

Share this content:
Recommendations Developed for Addressing Child Trafficking
Recommendations Developed for Addressing Child Trafficking

MONDAY, Nov. 27, 2017 (HealthDay News) -- In a policy statement published online Nov. 27 in Pediatrics, recommendations are presented for health care professionals to help prevent child trafficking, recognize victims, and intervene appropriately.

Jordan Greenbaum, M.D., from the Stephanie V. Blank Center for Safe and Healthy Children at Children's Healthcare of Atlanta, and Nia Bodrick, M.D., M.P.H., from Unity Health Care Inc. in Washington, D.C., developed the policy statement to address child trafficking prevention, identification, and intervention.

The researchers note that health care professionals need training in order to recognize signs of exploitation and intervene appropriately. The recommendations include development of public policy, supporting legislation and policies such as accessing services for victims, facilitating primary prevention through education, supporting efforts to address the social determinants of health, which may influence vulnerability to trafficking, and working with other medical organizations to facilitate a public health approach to human trafficking. More research is needed on child trafficking, including identification of risk factors, estimating prevalence, and exploring health consequences and outcomes. Health care professionals should be encouraged to develop and test referral mechanisms, including working with nonmedical professionals in the community, to facilitate connection of victims with appropriate service providers. In addition, health care professionals should be included as members of multidisciplinary teams combatting human trafficking.

"This policy statement outlines major issues regarding public policy, medical education, research, and collaboration in the area of child labor and sex trafficking and provides recommendations for future work," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »